PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

New York Presbyterian Hospital - Columbia University Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

lnstitut Paoli Calmettes, Marseille

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

NEXT Virginia, Fairfax

START MADRID - FJD Hospital Universitario Fundacion Jimenez Diaz, Madrid

Hospital Universitario HM Sanchinarro, Madrid

Winship Cancer Institute, Atlanta

Oncopole Claudius Regaud IUCT ONCOPOLE, Toulouse

Mayo Clinic, Jacksonville, Jacksonville

lnstitut Bergonie Centre Regionale de Lutte Contre le cancer, Service Oncologie-Medicale, Bordeaux

AdventHealth Medical Group Oncology Research at Celebration, Celebration

University Hospitals Cleveland Medical Center, Cleveland

Cleveland Clinic, Cleveland

Mayo Clinic, Rochester, Rochester

Northwestern Memorial Hospital, Chicago

Washington University School of Medicine - Siteman Cancer Center, St Louis

Centre Leon Berard, Lyon

The University of Texas MD Anderson Cancer Center, Houston

UCLA Hematology/Oncology - Santa Monica, Santa Monica

Institut Gustave Roussy, Villejuif

University of California, Davis Comprehensive Cancer Center, Sacramento

Providence Cancer Institute Franz Clinic, Portland

National University Hospital, Singapore

National Cancer Centre Singapore, Singapore

Smilow Cancer Hospital Phase 1 Unit, New Haven

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Leids Universitair Medisch Centrum, Leiden

START Barcelona - HM Nou Delfos, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona